Literature DB >> 7798533

Adenosine pharmacologic stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis. Diagnostic efficacy and comparison of clinical, hemodynamic and electrocardiographic variables with 100 age-matched control subjects.

B Samuels1, H Kiat, J D Friedman, D S Berman.   

Abstract

OBJECTIVES: This study assessed the safety and diagnostic accuracy of adenosine stress myocardial perfusion scintigraphy for the detection of coronary artery disease using single-photon emission computed tomography (SPECT) in patients with significant aortic stenosis.
BACKGROUND: Exercise cardiac stress testing in patients with significant aortic stenosis is generally avoided because of concerns for safety. In addition, those studies that have analyzed the utility of exercise testing both with and without myocardial thallium-201 scintigraphy for the diagnosis of coronary artery disease have yielded low specificity. Currently, no safe and accurate means exists to noninvasively assess the presence, extent and severity of coronary artery disease in patients with significant aortic stenosis.
METHODS: The study included 35 patients with moderate to severe aortic stenosis (mean [+/- SD] aortic valve area 0.84 +/- 0.16 cm2, range 0.5 to 1.2; mean maximal instantaneous aortic valve gradient 44.4 +/- 15.9 mm Hg, range 20 to 84). All patients underwent a 6-min adenosine infusion (140 micrograms/kg body weight per min) protocol and either separate acquisition rest thallium-201/stress technetium-99m sestamibi or stress and 4-h redistribution thallium-201 SPECT: Visual 20-segment SPECT analysis used a standard five-point scoring system from 0 (normal tracer uptake) to 4 (absent uptake). The SPECT results were considered abnormal if more than two segments had a stress score > or = 2. Hemodynamic, electrocardiographic and clinical responses were compared with those in a reference group of 100 consecutive age-matched patients undergoing adenosine SPECT who did not have aortic stenosis.
RESULTS: Hemodynamic responses during adenosine stress testing between the study and control patients demonstrated no significant difference in the net change in systolic blood pressure (18% of baseline vs. 14%, patients with aortic stenosis vs. control subjects), heart rate (21% vs. 19%), rate-pressure product (0% vs. 2%) or incidence of chest pain (23% vs. 35%) or transient second-(9% vs. 9%) or third-degree atrioventricular block (3% vs. 1%). In the 20 patients who had coronary angiography, sensitivity for detection of coronary artery disease was 92% (12 of 13) and specificity was 71% (5 of 7).
CONCLUSIONS: In this preliminary study, adenosine was found to be well tolerated and diagnostically accurate in patients with moderate to severe aortic stenosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7798533     DOI: 10.1016/0735-1097(94)00317-j

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  14 in total

Review 1.  Pathophysiology of valvular heart disease: implications for nuclear imaging.

Authors:  Blasé Carabello
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  The higher likelihood of developing cardiomegaly during follow-up in patients with syndrome X and abnormal thallium-201 myocardial perfusion SPECT.

Authors:  S S Sun; J L Huang; S C Tsai; Y J Ho; C H Kao
Journal:  Int J Cardiovasc Imaging       Date:  2001-08       Impact factor: 2.357

Review 3.  Myocardial perfusion and coronary microcirculation: from pathophysiology to clinical application.

Authors:  Antonio L'Abbate; Gianmario Sambuceti; Danilo Neglia
Journal:  J Nucl Cardiol       Date:  2002 May-Jun       Impact factor: 5.952

Review 4.  Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies.

Authors:  Vasken Dilsizian; Henry Gewirtz; Nicholas Paivanas; Anastasia N Kitsiou; Fadi G Hage; Nathan E Crone; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

5.  Adenosine stress myocardial perfusion imaging in octogenarians: Safety, tolerability, and long-term prognostic implications of hemodynamic response and SPECT-related variables.

Authors:  Athanasios Katsikis; Athanasios Theodorakos; Spyridon Papaioannou; Antonios Kalkinis; Genovefa Kolovou; Konstantinos Konstantinou; Maria Koutelou
Journal:  J Nucl Cardiol       Date:  2017-04-26       Impact factor: 5.952

6.  Stress positron emission tomography is safe and can guide coronary revascularization in high-risk patients being considered for transcatheter aortic valve replacement.

Authors:  Paul C Cremer; Shaden Khalaf; Junyang Lou; Leonardo Rodriguez; Manuel D Cerqueira; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2014-06-19       Impact factor: 5.952

7.  ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.

Authors:  Milena J Henzlova; W Lane Duvall; Andrew J Einstein; Mark I Travin; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2016-06       Impact factor: 5.952

8.  Adenosine myocardial perfusion single photon emission computed tomographic stress testing 24-72 h after uncomplicated myocardial infarction.

Authors:  Jan Kulhanek; Vincent L Sorrell; Reza E Ershadi; Brian R Cabarrus; Douglas B Short; Assad Movahed
Journal:  Int J Cardiovasc Imaging       Date:  2002-08       Impact factor: 2.357

9.  An assessment of the safety, hemodynamic response, and diagnostic accuracy of commonly used vasodilator stressors in patients with severe aortic stenosis.

Authors:  Nasir Hussain; Waseem Chaudhry; Alan W Ahlberg; Richard S Amara; Ahmed Elfar; Matthew W Parker; John A Savino; Ruwanthi Titano; Milena J Henzlova; William L Duvall
Journal:  J Nucl Cardiol       Date:  2016-03-15       Impact factor: 5.952

10.  Adenosine stress myocardial perfusion tomographic imaging in patients with significant aortic stenosis.

Authors:  Sotirios P Patsilinakos; Stavros Spanodimos; Fivi Rontoyanni; Athanasios Kranidis; Ioannis P Antonelis; Konstantinos Sotirellos; Dionysios Antonatos; Elias Tsaglis; Nikolaos Nikolaou; Dimitris Tsigas
Journal:  J Nucl Cardiol       Date:  2004 Jan-Feb       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.